Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.

× No keyword cloud information.

8 in total

1. 3-O-methyldopa, a new precursor of dopamine.

Authors: G Bartholini; I Kuruma; A Pletscher
Journal: Nature Date: 1971-04-23 Impact factor: 49.962

2. Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres.

Authors: O Hornykiewicz; H J Lisch; A Springer
Journal: Brain Res Date: 1968-12 Impact factor: 3.252

3. Aromatic amino acids and modification of parkinsonism.

Authors: G C Cotzias; M H Van Woert; L M Schiffer
Journal: N Engl J Med Date: 1967-02-16 Impact factor: 91.245

4. [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].

Authors: H Bernheimer; O Hornykiewicz
Journal: Klin Wochenschr Date: 1965-07-01

5. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors: W BIRKMAYER; O HORNYKIEWICZ
Journal: Wien Klin Wochenschr Date: 1961-11-10 Impact factor: 1.704

Review 6. Dopamine (3-hydroxytyramine) and brain function.

Authors: O Hornykiewicz
Journal: Pharmacol Rev Date: 1966-06 Impact factor: 25.468

7. L-Dopa-induced release of cerebral monoamines.

Authors: K Y Ng; T N Chase; R W Colburn; I J Kopin
Journal: Science Date: 1970-10-02 Impact factor: 47.728

8. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors: H EHRINGER; O HORNYKIEWICZ
Journal: Klin Wochenschr Date: 1960-12-15

8 in total

9 in total

1. The biochemical evaluation of psychotropic drugs.

Authors: A V Mackay
Journal: Br J Clin Pharmacol Date: 1976-02 Impact factor: 4.335

2. The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.

Authors: L D Lytle; O Hurko; J A Romero; K Cottman; D Leehey; R J Wurtman
Journal: J Neural Transm Date: 1972 Impact factor: 3.575

3. Effect of L-dopa on delayed response and visual discrimination in cats and its relation to brain chemistry.

Authors: A Kitsikis; A G Roberge; G Frenette
Journal: Exp Brain Res Date: 1972 Impact factor: 1.972

4. Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

Authors: A G Roberge; L J Poirier
Journal: J Neural Transm Date: 1973 Impact factor: 3.575

5. Lisuride, a potent drug in the treatment of muscular rigisity in rats.

Authors: D Loos; K Halbhübner; H Herken
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-11 Impact factor: 3.000

6. Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.

Authors: P Riederer; S Wuketich
Journal: J Neural Transm Date: 1976 Impact factor: 3.575

L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.